217 related articles for article (PubMed ID: 10232503)
1. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.
Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE
Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503
[TBL] [Abstract][Full Text] [Related]
2. Inadequate suppression of angiotensin II modulates left ventricular structure in humans.
Schlaich MP; Schobel HP; Langenfeld MR; Hilgers K; Schmieder RE
Clin Nephrol; 1998 Mar; 49(3):153-9. PubMed ID: 9543596
[TBL] [Abstract][Full Text] [Related]
3. Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects.
Klingbeil AU; Schobel H; Langenfeld MR; Hilgers K; Schäufele T; Schmieder RE
J Hypertens; 1999 Jun; 17(6):825-33. PubMed ID: 10459881
[TBL] [Abstract][Full Text] [Related]
4. [Arterial hypertension, left ventricular hypertrophy and arrhythmias].
González Maqueda I
Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211
[TBL] [Abstract][Full Text] [Related]
5. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
[TBL] [Abstract][Full Text] [Related]
6. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
7. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
[TBL] [Abstract][Full Text] [Related]
8. Natriuresis-pressure relationship in polycystic kidney disease.
Schmid M; Mann JF; Stein G; Herter M; Nussberger J; Klingbeil A; Ritz E
J Hypertens; 1990 Mar; 8(3):277-83. PubMed ID: 2159509
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
van Hooft IM; Grobbee DE; Derkx FH; de Leeuw PW; Schalekamp MA; Hofman A
N Engl J Med; 1991 May; 324(19):1305-11. PubMed ID: 2017226
[TBL] [Abstract][Full Text] [Related]
13. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
14. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
15. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension.
Widgren BR; Herlitz H; Aurell M; Berglund G; Wikstrand J; Andersson OK
Am J Hypertens; 1992 Mar; 5(3):167-74. PubMed ID: 1575943
[TBL] [Abstract][Full Text] [Related]
16. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension.
Fesler P; Safar ME; du Cailar G; Ribstein J; Mimran A
J Hypertens; 2007 Sep; 25(9):1915-20. PubMed ID: 17762657
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
20. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
